Skip to main content
Log in

Calcium pyrophosphate deposition (CPPD) in a liver transplant patient: are hypomagnesemia, tacrolimus or both guilty? A case-based literature review

  • Case Based Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Calcium pyrophosphate deposition (CPPD) can be induced by a persistent hypomagnesemia. Tacrolimus is an immunosuppressive treatment especially used in organ transplant, potentially inducer of hypomagnesemia by renal loss. A 53-year-old man, liver transplant 10 months earlier, developed an acute peripheral oligoarthritis of wrist, hip and elbow with fever, associated with acute low back pain. Synovial fluid was sterile, and revealed calcium pyrophosphate crystals. Spinal imaging showed inflammatory changes. Magnesium blood level was low at 0.51 mmol/l, with high fractional excretion in favor of renal loss. Tacrolimus was changed for everolimus, proton pump inhibitor was stopped, and magnesium oral supplementation was started. After 8 months follow-up and slow prednisone tapering, he did not relapse pain. Persistent hypomagnesemia is a rare secondary cause of CPPD. In this entity, drug liability should be investigated such as tacrolimus in organ transplant patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rosenthal AK, Ryan LM (2016) Calcium pyrophosphate deposition disease. N Engl J Med 374:2575–2584. https://doi.org/10.1056/NEJMra1511117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Moshrif A, Laredo JD, Bassiouni H et al (2019) Spinal involvement with calcium pyrophosphate deposition disease in an academic rheumatology center: a series of 37 patients. Semin Arthritis Rheum 48:1113–1126. https://doi.org/10.1016/j.semarthrit.2018.10.009

    Article  CAS  PubMed  Google Scholar 

  3. Grobost V, Vayssade M, Roche A et al (2014) Axial calcium pyrophosphate dihydrate deposition disease revealed by recurrent sterile spondylodiscitis and epidural abscess. Joint Bone Spine 81:180–182. https://doi.org/10.1016/j.jbspin.2013.07.007

    Article  CAS  PubMed  Google Scholar 

  4. Jones AC, Chuck AJ, Arie EA et al (1992) Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 22:188–202. https://doi.org/10.1016/0049-0172(92)90019-a

    Article  CAS  PubMed  Google Scholar 

  5. Ea H-K, Blanchard A, Dougados M, Roux C (2005) Chondrocalcinosis secondary to hypomagnesemia in Gitelman’s syndrome. J Rheumatol 32:1840–1842

    PubMed  Google Scholar 

  6. Cipolletta E, Di Matteo A, Filippucci E, Grassi W (2019) Calcium pyrophosphate deposition disease in a patient with familial hypokalemia-hypomagnesemia (Gitelman’s-Syndrome): a case report. Ultraschall Med. https://doi.org/10.1055/a-0990-9960

    Article  PubMed  Google Scholar 

  7. Richette P, Ayoub G, Bardin T et al (2005) Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol 32:2434–2436

    PubMed  Google Scholar 

  8. Nijenhuis T, Hoenderop JGJ, Bindels RJM (2004) Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 15:549–557. https://doi.org/10.1097/01.asn.0000113318.56023.b6

    Article  CAS  PubMed  Google Scholar 

  9. Favero M, Calò LA, Schiavon F, Punzi L (2011) Miscellaneous non-inflammatory musculoskeletal conditions. Bartter’s and Gitelman’s diseases. Best Pract Res Clin Rheumatol 25:637–648. https://doi.org/10.1016/j.berh.2011.10.013

    Article  CAS  PubMed  Google Scholar 

  10. Guerne P-A (2010) Chondrocalcinosis and calcium pyrophosphate (CPP) crystal deposition disease in 2010. Revue Medicale Suisse 6:555–556

    PubMed  Google Scholar 

  11. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W et al (2015) Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail 37:1237–1241. https://doi.org/10.3109/0886022X.2015.1057800

    Article  CAS  PubMed  Google Scholar 

  12. Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM (2001) “Pseudoseptic” pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation 71:696–698. https://doi.org/10.1097/00007890-200103150-00022

    Article  CAS  PubMed  Google Scholar 

  13. Diep JT, Kerr LD, Barton C, Emre S (2008) Musculoskeletal manifestations in liver transplantation recipients. J Clin Rheumatol Pract Rep Rheum Musculoskel Dis 14:257–260. https://doi.org/10.1097/RHU.0b013e3181870212

    Article  Google Scholar 

  14. Cenin DA, Freyer CW, Ligon CB et al (2020) Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplant. J Oncol Pharm Pract. https://doi.org/10.1177/1078155220951241

    Article  PubMed  Google Scholar 

  15. Martinon F, Pétrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. https://doi.org/10.1038/nature04516

    Article  CAS  PubMed  Google Scholar 

  16. Mariathasan S, Newton K, Monack DM et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213–218. https://doi.org/10.1038/nature02664

    Article  CAS  PubMed  Google Scholar 

  17. Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5:i3–i14. https://doi.org/10.1093/ndtplus/sfr163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Srinutta T, Chewcharat A, Takkavatakarn K et al (2019) Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies. Med (Baltim) 98:e17788. https://doi.org/10.1097/MD.0000000000017788

    Article  Google Scholar 

  19. Sivakumar J (2016) Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review. Int J Physiol Pathophysiol Pharmacol 8:169–174

    PubMed  PubMed Central  Google Scholar 

  20. Kleiber Balderrama C, Rosenthal AK, Lans D et al (2017) Calcium pyrophosphate deposition disease and associated medical comorbidities: a national cross-sectional study of US veterans. Arthritis Care Res (Hoboken) 69:1400–1406. https://doi.org/10.1002/acr.23160

    Article  CAS  Google Scholar 

  21. Amanova A, Kendi Celebi Z, Bakar F et al (2014) Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. Clin Transplant 28:1177–1183. https://doi.org/10.1111/ctr.12448

    Article  CAS  PubMed  Google Scholar 

  22. Yousuf Bhat Z, Reddy S, Pillai U et al (2016) Colchicine-induced myopathy in a tacrolimus-treated renal transplant recipient: case report and literature review. Am J Ther 23:e614-616. https://doi.org/10.1097/MJT.0000000000000044

    Article  PubMed  Google Scholar 

  23. Nguyen LS, Vautier M, Allenbach Y et al (2019) Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation. Drug Saf 42:813–825. https://doi.org/10.1007/s40264-019-00810-9

    Article  CAS  PubMed  Google Scholar 

  24. Kolaitis NA, Calabrese DR, Ahearn P et al (2019) Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients. Am J Health Syst Pharm 76:2019–2027. https://doi.org/10.1093/ajhp/zxz243

    Article  PubMed  PubMed Central  Google Scholar 

  25. Zhang W, Doherty M, Pascual E et al (2011) EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 70:571–575. https://doi.org/10.1136/ard.2010.139360

    Article  CAS  PubMed  Google Scholar 

  26. Alvarellos A, Spilberg I (1986) Colchicine prophylaxis in pseudogout. J Rheumatol 13:804–805

    CAS  PubMed  Google Scholar 

  27. Grotz WH, Breitenfeldt MK, Braune SW et al (2001) Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation. Transpl Int 14:16–23. https://doi.org/10.1007/s001470000285

    Article  CAS  PubMed  Google Scholar 

  28. Rozenberg S, Bourgeois P (1995) Osteo-articular complications of heart transplantation. Presse Med 24:1809–1812

    CAS  PubMed  Google Scholar 

  29. Udomkarnjananun S, Townamchai N, Virojanawat M et al (2018) An unusual manifestation of calcineurin inhibitor-induced pain syndrome in kidney transplantation: a case report and literature review. Am J Case Rep 19:442–446. https://doi.org/10.12659/ajcr.908886

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lee RS, Kayser MV, Ali SY (2006) Calcium phosphate microcrystal deposition in the human intervertebral disc. J Anat 208:13–19. https://doi.org/10.1111/j.1469-7580.2006.00504.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SC, for conception and design, acquisition and interpretation of data and drafting of manuscript. ALG, for case management and revising critically the manuscript. BG, for acquisition of data and revising critically the manuscript. FR, for design and drafting of systematic literature review and revising critically the manuscript. MM, for case management and revising critically the manuscript. XG, for conception and revising critically the manuscript. GP, for conception and design, drafting and revising critically the manuscript. MSR, for case management, conception and design, acquisition of data and revising the manuscript. All the authors approve this final version and agree to be accountable for all aspects of the work if questions arise related to its accuracy or integrity.

Corresponding author

Correspondence to Simon Cadiou.

Ethics declarations

Conflict of interest

None of the authors have conflict of interest to declare for this article.

Informed consent

Patient gave consent to participate and for publishing.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cadiou, S., Le Gruyer, A., Giguet, B. et al. Calcium pyrophosphate deposition (CPPD) in a liver transplant patient: are hypomagnesemia, tacrolimus or both guilty? A case-based literature review. Rheumatol Int 42, 1105–1112 (2022). https://doi.org/10.1007/s00296-021-04828-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04828-0

Keywords

Navigation